(Q36391656)

English

Rostafuroxin: an ouabain antagonist that corrects renal and vascular Na+-K+- ATPase alterations in ouabain and adducin-dependent hypertension

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

13 August 2017

1 reference

Europe PubMed Central

Rostafuroxin: an ouabain antagonist that corrects renal and vascular Na+-K+- ATPase alterations in ouabain and adducin-dependent hypertension (English)

1 reference

Europe PubMed Central

13 August 2017

arterial hypertension

0 references

Giuseppe Bianchi

4

object named as

Giuseppe Bianchi

1 reference

Europe PubMed Central

13 August 2017

author name string

Patrizia Ferrari

1

1 reference

Europe PubMed Central

13 August 2017

Mara Ferrandi

2

1 reference

Europe PubMed Central

13 August 2017

Giovanni Valentini

3

1 reference

Europe PubMed Central

13 August 2017

publication date

1 March 2006

1 reference

Europe PubMed Central

13 August 2017

American Journal of Physiology - Regulatory, Integrative and Comparative Physiology

1 reference

Europe PubMed Central

13 August 2017

290

1 reference

Europe PubMed Central

13 August 2017

3

1 reference

Europe PubMed Central

13 August 2017

R529-35

1 reference

Europe PubMed Central

13 August 2017

Two point mutations within the adducin genes are involved in blood pressure variation

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00518.2005

21 January 2018

Pharmacogenomics of primary hypertension--the lessons from the past to look toward the future

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00518.2005

21 January 2018

Adducin polymorphism: detection and impact on hypertension and related disorders

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00518.2005

21 January 2018

Genetic variations of tubular sodium reabsorption leading to "primary" hypertension: from gene polymorphism to clinical symptoms

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00518.2005

21 January 2018

Polymorphisms of alpha-adducin and salt sensitivity in patients with essential hypertension

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00518.2005

21 January 2018

Plasma levels of an endogenous Na(+)-K+ pump inhibitor in relation to haemodynamic data in cardiopathic patients

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00518.2005

21 January 2018

The alpha2-isoform of Na-K-ATPase mediates ouabain-induced hypertension in mice and increased vascular contractility in vitro

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00518.2005

21 January 2018

Hypertension-linked mutation in the adducin alpha-subunit leads to higher AP2-mu2 phosphorylation and impaired Na+,K+-ATPase trafficking in response to GPCR signals and intracellular sodium

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00518.2005

21 January 2018

Ouabain-like factor quantification in mammalian tissues and plasma: comparison of two independent assays.

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00518.2005

21 January 2018

PST 2238: a new antihypertensive compound that modulates renal Na-K pump function without diuretic activity in Milan hypertensive rats

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00518.2005

21 January 2018

The endogenous ouabain: molecular basis of its role in hypertension and cardiovascular complications

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00518.2005

21 January 2018

An approach to the development of novel antihypertensive drugs: potential role of sodium pump inhibitors

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00518.2005

21 January 2018

Observations on the nature, biosynthesis, secretion and significance of endogenous ouabain

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00518.2005

21 January 2018

Salt-sensitive hypertension is triggered by Ca2+ entry via Na+/Ca2+ exchanger type-1 in vascular smooth muscle

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00518.2005

21 January 2018

Different effects of in vivo ouabain and digoxin on renal artery function and blood pressure in the rat.

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00518.2005

21 January 2018

Molecular genetics of human blood pressure variation

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00518.2005

21 January 2018

Left ventricular mass, stroke volume, and ouabain-like factor in essential hypertension

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00518.2005

21 January 2018

Plasma ouabain-like factor during acute and chronic changes in sodium balance in essential hypertension.

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00518.2005

21 January 2018

Endogenous ouabain: upregulation of steroidogenic genes in hypertensive hypothalamus but not adrenal

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00518.2005

21 January 2018

Humoral Na+-K+ pump inhibitory activity in essential hypertension and in normotensive subjects after acute volume expansion

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00518.2005

21 January 2018

Endogenous ouabain and hemodynamic and left ventricular geometric patterns in essential hypertension

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00518.2005

21 January 2018

Independent and incremental prognostic value of endogenous ouabain in idiopathic dilated cardiomyopathy

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00518.2005

21 January 2018

Immunoreactive endogenous ouabain primary aldosteronism and essential hypertension: relationship with plasma renin, aldosterone and blood pressure levels

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00518.2005

21 January 2018

OASIS-HT: design of a pharmacogenomic dose-finding study

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00518.2005

21 January 2018

Monogenic forms of human hypertension

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00518.2005

21 January 2018

Hypertension-associated point mutations in the adducin alpha and beta subunits affect actin cytoskeleton and ion transport

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00518.2005

21 January 2018

High remaining risk in poorly treated hypertension: the ‘rule of halves’ still exists

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00518.2005

21 January 2018

A circulating inhibitor of (Na+ + K+) ATPase associated with essential hypertension

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00518.2005

21 January 2018

Identifiers

10.1152/AJPREGU.00518.2005

1 reference

Europe PubMed Central

13 August 2017

1 reference

Europe PubMed Central

13 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36391656&oldid=1629198605"